These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetic study of piliation in Escherichia coli: implications for understanding microbe-host interactions at the molecular level. Orndorff PE Pathol Immunopathol Res; 1987; 6(2):82-92. PubMed ID: 2892189 [No Abstract] [Full Text] [Related]
6. Pathogenesis of urinary tract infections: host susceptibility and bacterial virulence factors. Brettman LR Urology; 1988 Sep; 32(3 Suppl):9-11. PubMed ID: 2901798 [No Abstract] [Full Text] [Related]
7. Bacterial adherence in urinary tract infections caused by Escherichia coli. Svanborg Edén C Scand J Urol Nephrol; 1986; 20(2):81-8. PubMed ID: 2875519 [No Abstract] [Full Text] [Related]
8. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections]. Krzeska I; Ostojska J; Dzierzanowska D Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812 [TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporin on uropathogenic Escherichia coli adherence to human endothelial cells. Szkaradkiewicz A; Wal M Int J Antimicrob Agents; 2001 Jul; 18(1):89-91. PubMed ID: 11463534 [TBL] [Abstract][Full Text] [Related]
11. [Tamm-Horsfall protein--uromodulin]. Duława J; Kokot M Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):700-2. PubMed ID: 1492042 [No Abstract] [Full Text] [Related]
12. Glycolipid receptors of F1C fimbrial adhesin of uropathogenic Escherichia coli. Khan AS; Hacker J Adv Exp Med Biol; 2000; 485():213-7. PubMed ID: 11109108 [No Abstract] [Full Text] [Related]
13. Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli. Latrache H; Bourlioux P; Karroua M; Zahir H; Hakkou A Folia Microbiol (Praha); 2000; 45(6):485-90. PubMed ID: 11501411 [TBL] [Abstract][Full Text] [Related]
14. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Berger RE J Urol; 2005 Nov; 174(5):1843. PubMed ID: 16217309 [No Abstract] [Full Text] [Related]
15. Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli. Schilling JD; Hultgren SJ Int J Antimicrob Agents; 2002 Jun; 19(6):457-60. PubMed ID: 12135832 [TBL] [Abstract][Full Text] [Related]
16. Bacterial adherence to periurethral epithelial cells in women with urinary tract infection. Raghoji NS; Sengupta SR Indian J Med Res; 1983 Jun; 77():802-7. PubMed ID: 6358009 [No Abstract] [Full Text] [Related]
17. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Eisenstein BI; Jones GW Adv Intern Med; 1988; 33():231-52. PubMed ID: 2830769 [No Abstract] [Full Text] [Related]
18. Covert operations of uropathogenic Escherichia coli within the urinary tract. Bower JM; Eto DS; Mulvey MA Traffic; 2005 Jan; 6(1):18-31. PubMed ID: 15569242 [TBL] [Abstract][Full Text] [Related]
19. Increased risk of urinary tract infection associated with the use of calcium supplements. Apicella LL; Sobota AE Urol Res; 1990; 18(3):213-7. PubMed ID: 2204174 [TBL] [Abstract][Full Text] [Related]
20. Renal involvement in urinary tract infection. Svanborg C; de Man P; Sandberg T Kidney Int; 1991 Mar; 39(3):541-9. PubMed ID: 2062037 [No Abstract] [Full Text] [Related] [Next] [New Search]